Hope Is Still the Main Catalyst<br /><br />By Rev Shark<br />RealMoney.com Contributor<br />4/1/2008 8:47 AM EDT <br /><br />The trouble with most people is that they think with their hopes or fears or wishes rather than with their minds. <br /> --Will Durant <br /><br /><br />There is hope in the air as we kick off the second quarter of 2008. The news flow has been so poor and the market action has been so dismal so far this year that a little hope has to emerge at some point to provide a little relief. Markets, even ones as bad as this one has been, don't simply go straight down. <br /><br />Although the mood is a bit more upbeat this morning, which is often the case when we start a new month, the market is still in very troubling shape. We seem to have gotten gloomy and negative enough to support some sort of relief bounce but we have a tremendous amount of work to do before the longer-term picture will begin to improve. <br /><br />The very light volume and poor mood is the sort of action you'd expect to see as we are scraping along the bottom, but it would be foolish to let hope drive us to believe that we won't have more problems to come at some point. <br /><br />Like many others, I'm finding this market extremely difficult to deal with. The very light volume and the random volatility makes building positions extremely hard. Even the tendency to have little selloffs into the close and then strong opens the next morning makes trying to develop a workable strategy almost impossible. <br /><br />My game plan at this point remains much the same. I see no reason to conclude that the overall downtrend is ending so I am unable to build longer term positions. On the other hand, we are setup well for some bounces and counter-trend rallies as things have gotten gloomy and the level of indifference high. <br /><br />I'd much rather build some positions I can hold for months but I see nothing to support such a move at this time. With earnings season coming up, such an approach is even more questionable. So that leaves us with nothing more than a lot of patience and a short-term time frame. <br /><br />I really would love to sound the all clear and proclaim like many others that we should be jumping into this market with both feet. However to do so would simply be allowing hope to dictate over the clear technical patterns that still require caution. <br /><br />We have some upside action to start the day and maybe that will attract some buyers who are anxious to do something, but if you aren't keeping time frames short you haven't been paying attention. <br /><br /><br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: CDS +7.6%, SPIR +4.2%, GSI +3.6%, OXM +1.3%... M&A news: CAO +18.2% (to be acquired by O'Reilly for $11.00 of O'Reilly common stock plus $1.00 in cash)... Select financial names showing strength with a number of news items out: UBS +8.1% (co releases financial update, seeks fresh capital and expects $19 bln in write-downs; chairman will depart; also upgraded to Buy at Deutsche Bank), BCS +5.0%, RBS +4.1%, LEH +3.6% (to offer 3 mln shares of convertible preferred stock; analyst commentary on offering is generally positive), WM +3.5%, WFC +3.1%, DB +2.9% (faces write-downs of about $3.95 bln), WB +2.8%, MER +1.9%, MS +1.9%, DB +1.8%, C +1.8%... Other news: TMA +35.5% (raised $1.35 bln through private placement of senior subordinated secured notes and warrants), CEGE +34.9% (Cell Genesys and Takeda announce global alliance for the development and commercialization of GVAX immunotherapy for prostate cancer), IMH +18.1% (announces the co has settled a majority of repurchase liabilities), ATN +4.9% (Cramer makes positive comments on MadMoney), VVUS +4.5% (completes special protocol assessment for Phase 3 efficacy studies and reaches agreement with FTA on the studies), NOK +3.8% (still checking), MOT +2.5% (Videocon to bid for Motorola's global mobile business, Chairman says - DJ), SRDX +2.3% (announces first human use of SynBiosys biodegradable polymer on cardiomind drug-eluting stent), STP +2.0% (Nitol Solar and Suntech expand Polysilicon supply agreement), DELL +1.4% (undertaking a strategic assessment of ownership alternatives for its Dell Financial Services financing activities), CYTK +1.2% (announces CK-1827452 demonstrates increase in left ventricular function with no increase in myocardial oxygen consumption in canine model), BAP +1.1% (Cramer makes positive comments on MadMoney)... Analyst upgrades: HANS +4.8% (upgraded to Buy at tier 1 firm), PIR +4.5% (upgraded to Buy at Deutsche Bank and initiated with a Buy at Jesup and Lamont), BWLD +4.1% (upgraded to Outperform at Keefe Bruyette), AKAM +3.6% (upgraded to Buy at Piper), AZN +3.5% (upgraded to Neutral at JPMorgan), ANSS +3.0% (upgraded to Buy at Jefferies), ATHR +2.8% (upgraded to Overwt at Weisel), VMW +2.8% (upgraded to Outperform at Wachovia), WBD +2.6% (upgraded to Buy at Merrill).<br /><br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance: GBN -7.1%, BUF -6.4%, PCL -4.2%, RMG -4.1%, KRY -3.1%, TISI -3.1%, CNO -2.9%, APWR -1.0%... Select metals/mining stocks showing weakness with lower spot prices on strength in the dollar: PAL -5.3%, KGC -4.1%, HMY -3.5%, GOLD -3.1%, HL -3.0%, AU -2.8%, CDE -2.7%, ABX -2.5%, GLD -2.4%, SLV -2.4%, GFI -2.3%, MT -2.0%, RTP -1.8%, NEM -1.8% (Newmont Indonesia offers to sell 7% to govt - Reuters.com)... Other news: TMY -9.0% (terminates merger agreement), KFN -4.4% (announces proposed common share offering of 20 mln common shares; also downgraded to Peer Perform at Bear Sterns), ANR -4.0% (announces launch of capital markets transactions), YHOO -2.5% (Microsoft unlikely to raise Yahoo offer - WSJ)... Analyst downgrades: AVCT -5.3% (downgraded to Sector Perform at RBC), HPT -4.5% (downgraded to Underperform from Market Perform at Wachovia), MO -3.6% (downgraded to Equal Wt at Morgan Stanley).